Cryoport(CYRX)
Search documents
Cryoport(CYRX) - 2020 Q4 - Annual Report
2021-03-01 22:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 (State or other juris ...
Cryoport(CYRX) - 2020 Q3 - Earnings Call Transcript
2020-11-08 13:24
Cryoport, Inc. (NASDAQ:CYRX) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Todd Fromer - Managing Partner, KCSA Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development & Investor Relations Conference Call Participants Andrew D'Silva - B. Riley Securities Joseph Conway - Needham & Company Operator Good day everyone, and welcome to the Cryoport Incor ...
Cryoport(CYRX) - 2020 Q3 - Quarterly Report
2020-11-06 22:19
Table of Contents Title of each class: Trading Symbol(s) Name of each exchange on which registered: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOP ...
Cryoport(CYRX) - 2020 Q2 - Quarterly Report
2020-08-10 19:20
Table of Contents Title of each class: Trading Symbol(s) Name of each exchange on which registered: Common Stock , $0.001 par value CYRX The Nasdaq Stock Market LLC (The Nasdaq Capital Market) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...
Cryoport(CYRX) - 2020 Q2 - Earnings Call Transcript
2020-08-09 05:09
Cryoport, Inc. (NASDAQ:CYRX) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Todd Fromer - Managing Partner, KCSA Jerrell Shelton - CEO Mark Sawicki - CCO Robert Stefanovich - CFO Thomas Heinzen - VP, Corporate Development and Investor Relations Conference Call Participants Jacob Johnson - Stephens Steve Unger - Needham Andrew D'Silva - B. Riley FBR Brandon Couillard - Jefferies Operator Good day, and welcome to the Cryoport, Inc.'s Second Quarter 2020 Earnings Results Call. ...
Cryoport(CYRX) - 2020 Q1 - Earnings Call Transcript
2020-05-10 10:59
Cryoport, Inc. (NASDAQ:CYRX) Q1 2020 Earnings Conference Call May 7, 2020 5:00 PM ET Company Participants Todd Fromer - Managing Partner, KCSA Jerrell Shelton - CEO Mark Sawicki - CCO Robert Stefanovich - CFO Conference Call Participants Scott Mafale - SVB Leerink Brandon Couillard - Jefferies Paul Knight - Janney Jacob Johnson - Stephens Steve Unger - Needham Andrew D'Silva - B. Riley FBR Operator Thank you for standing by. This is the conference operator. Welcome to the Cryoport, Inc.'s First Quarter 2020 ...
Cryoport(CYRX) - 2020 Q1 - Quarterly Report
2020-05-08 20:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class: Trading Symbol(s) Name of each exchange on which registered: Common Stock, $0.001 par value CYRX The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Warrants to purchase Common Stock CYRXW The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ¨ TRANSITION ...
Cryoport(CYRX) - 2019 Q4 - Annual Report
2020-03-10 20:39
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Common Stock, $0.001 par value CYRX The NASDAQ Stock Market LLC Warrants to purchase Common Stock CYRXW The NASDAQ Stock Market LLC FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File ...
Cryoport(CYRX) - 2019 Q4 - Earnings Call Transcript
2020-03-06 01:13
Cryoport, Inc. (NASDAQ:CYRX) Q4 2019 Earnings Conference Call March 5, 2020 5:00 PM ET Operator Company Participants | --- | |--------------------------------------------------------------------------------| | | | Todd Fromer - Managing Partner, KCSA Jerrell Shelton - Chief Executive Officer | | Robert Stefanovich - Chief Financial Officer | | Mark Sawicki - Chief Commercial Officer | | Conference Call Participants | | Puneet Souda - SVB Leerink | | Paul Knight - Janney Montgomery | | Richard Baldry - ROTH ...
Cryoport(CYRX) - 2019 Q3 - Quarterly Report
2019-11-12 18:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Title of each class: Trading Symbol(s) Name of each exchange on which registered: Common Stock CYRX The Nasdaq Capital Market Registered Warrants CYRXW The Nasdaq Capital Market x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 For the quarterly period ended September 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number ...